echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > HLA DR-DQ Genotyping by Capillary Electrophoresis for Risk Assessment for Celiac Disease

    HLA DR-DQ Genotyping by Capillary Electrophoresis for Risk Assessment for Celiac Disease

    • Last Update: 2020-12-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    The risk for celiac disease (CD) is clearly related to specific HLA D
    QA
    1 and DQB1 alleles, but HLA �typing is often consideredtoo costly for frequent use.
    Here we present a method using sequence-specific primed
    PCR
    (PCR-SSP) for HLA-DR-DQ genotyping optimized for capillary electrophoresison Applied Biosystems 3130
    xl
    Genetic Analyzer. Requiring a total of three PCR reactions and a single electrophoretic step, this method reduces the reagentexpenses and technical time for directed HLA typing to distinguish risk alleles for CD, with a sufficient throughput for large-scalescreening projects.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.